BIRC3
Summary: This gene encodes a member of the IAP family of proteins that inhibit apoptosis by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. The encoded protein inhibits apoptosis induced by serum deprivation but does not affect apoptosis resulting from exposure to menadione, a potent inducer of free radicals. It contains 3 baculovirus IAP repeats and a ring finger domain. Transcript variants encoding the same isoform have been identified. [provided by RefSeq, Aug 2011].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
baculoviral IAP repeat containing 3 | MIM:601721 | Ensembl:ENSG00000023445 | HGNC:HGNC:591 | PA25360 | 11q22.2 |
GO terms in BIRC3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | EXP | GO:0004842 | ubiquitin-protein transferase activity |
MF | IDA | GO:0004842 | ubiquitin-protein transferase activity |
MF | TAS | GO:0004842 | ubiquitin-protein transferase activity |
MF | IPI | GO:0005515 | protein binding |
MF | EXP | GO:0016740 | transferase activity |
MF | IBA | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
MF | IEA | GO:0046872 | metal ion binding |
MF | IBA | GO:0061630 | ubiquitin protein ligase activity |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
CC | IEA | GO:0032991 | protein-containing complex |
CC | IEA | GO:0045121 | membrane raft |
BP | IEA | GO:0006915 | apoptotic process |
BP | TAS | GO:0007166 | cell surface receptor signaling pathway |
BP | TAS | GO:0007249 | I-kappaB kinase/NF-kappaB signaling |
BP | IEA | GO:0007283 | spermatogenesis |
BP | TAS | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway |
BP | IEA | GO:0016567 | protein ubiquitination |
BP | TAS | GO:0016579 | protein deubiquitination |
BP | IDA | GO:0031398 | positive regulation of protein ubiquitination |
BP | TAS | GO:0033209 | tumor necrosis factor-mediated signaling pathway |
BP | TAS | GO:0034121 | regulation of toll-like receptor signaling pathway |
BP | TAS | GO:0038061 | NIK/NF-kappaB signaling |
BP | TAS | GO:0039535 | regulation of RIG-I signaling pathway |
BP | IMP | GO:0042981 | regulation of apoptotic process |
BP | TAS | GO:0043066 | negative regulation of apoptotic process |
BP | TAS | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
BP | TAS | GO:0045088 | regulation of innate immune response |
BP | TAS | GO:0050727 | regulation of inflammatory response |
BP | IEA | GO:0051291 | protein heterooligomerization |
BP | IMP | GO:0060544 | regulation of necroptotic process |
BP | TAS | GO:0060544 | regulation of necroptotic process |
BP | IBA | GO:0060546 | negative regulation of necroptotic process |
BP | TAS | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
BP | IBA | GO:0090307 | mitotic spindle assembly |
BP | IBA | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
BP | TAS | GO:2000116 | regulation of cysteine-type endopeptidase activity |
Gene expression in normal tissue: BIRC3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in BIRC3
Database | Pathway ID | Pathway Des. |
---|---|---|
pid | caspase_pathway | Caspase Cascade in Apoptosis |
pid | cd40_pathway | CD40/CD40L signaling |
pid | ceramide_pathway | Ceramide signaling pathway |
pid | cmyb_pathway | C-MYB transcription factor network |
pid | faspathway | FAS (CD95) signaling pathway |
pid | hivnefpathway | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
pid | p75ntrpathway | p75(NTR)-mediated signaling |
pid | tnfpathway | TNF receptor signaling pathway |
netpath | Pathway_TNFalpha | TNFalpha |
kegg | hsa04064 | NF-kappa B signaling pathway - Homo sapiens (human) |
kegg | hsa04120 | Ubiquitin mediated proteolysis - Homo sapiens (human) |
kegg | hsa04210 | Apoptosis - Homo sapiens (human) |
kegg | hsa04215 | Apoptosis - multiple species - Homo sapiens (human) |
kegg | hsa04217 | Necroptosis - Homo sapiens (human) |
kegg | hsa04510 | Focal adhesion - Homo sapiens (human) |
kegg | hsa04621 | NOD-like receptor signaling pathway - Homo sapiens (human) |
kegg | hsa04668 | TNF signaling pathway - Homo sapiens (human) |
kegg | hsa05145 | Toxoplasmosis - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05222 | Small cell lung cancer - Homo sapiens (human) |
wikipathways | WP1772 | Apoptosis Modulation and Signaling |
wikipathways | WP2036 | TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway |
wikipathways | WP231 | TNF alpha Signaling Pathway |
wikipathways | WP254 | Apoptosis |
wikipathways | WP2880 | Glucocorticoid Receptor Pathway |
wikipathways | WP2882 | Nuclear Receptors Meta-Pathway |
wikipathways | WP306 | Focal Adhesion |
wikipathways | WP3617 | Photodynamic therapy-induced NF-kB survival signaling |
wikipathways | WP3639 | Apoptotic Signaling Pathway |
wikipathways | WP3646 | Hepatitis C and Hepatocellular Carcinoma |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade |
reactome | R-HSA-166166 | MyD88-independent TLR4 cascade |
reactome | R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-168638 | NOD1/2 Signaling Pathway |
reactome | R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
reactome | R-HSA-168898 | Toll-Like Receptors Cascades |
reactome | R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-5213460 | RIPK1-mediated regulated necrosis |
reactome | R-HSA-5218859 | Regulated Necrosis |
reactome | R-HSA-5357801 | Programmed Cell Death |
reactome | R-HSA-5357905 | Regulation of TNFR1 signaling |
reactome | R-HSA-5357956 | TNFR1-induced NFkappaB signaling pathway |
reactome | R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway |
reactome | R-HSA-5675482 | Regulation of necroptotic cell death |
reactome | R-HSA-5676594 | TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway |
reactome | R-HSA-5688426 | Deubiquitination |
reactome | R-HSA-5689880 | Ub-specific processing proteases |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-73887 | Death Receptor Signalling |
reactome | R-HSA-75893 | TNF signaling |
reactome | R-HSA-937041 | IKK complex recruitment mediated by RIP1 |
reactome | R-HSA-937061 | TRIF(TICAM1)-mediated TLR4 signaling |
biocarta | caspasepathway | caspase cascade in apoptosis |
biocarta | ceramidepathway | ceramide signaling pathway |
biocarta | hivnefpathway | hiv-1 nef: negative effector of fas and tnf |
biocarta | keratinocytepathway | keratinocyte differentiation |
biocarta | mitochondriapathway | role of mitochondria in apoptotic signaling |
biocarta | soddpathway | sodd/tnfr1 signaling pathway |
biocarta | tnfr1pathway | tnfr1 signaling pathway |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD399 | Selumetinib | 3 |
iGMDRD398 | Sepantronium | 3 |
iGMDRD322 | FK 866 | 3 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD121 | GMX1778 | 6 |
iGMDRD202 | Curcumin | 3 |
iGMDRD134 | Sorafenib | 2 |
iGMDRD782 | DC-45-A2 | 3 |
iGMDRD105 | Triptolide | 3 |
iGMDRD289 | Parthenolide | 1 |
iGMDRD294 | Batimastat | 3 |
iGMDRD318 | PAC-1 | 7 |
iGMDRD152 | 179324-69-7 | 3 |
iGMDRD945 | ML214 | 6 |
iGMDRD210 | AC55649 | 3 |
iGMDRD126 | Tipifarnib | 6 |
iGMDRD607 | Ubistatin B | 3 |
iGMDRD79 | Gemcitabine | 3 |
iGMDRD494 | Neopeltolide | 6 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in BIRC3